Clinical trials
Overweight trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
182 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 11 |
| 2013 | 10 |
| 2014 | 6 |
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 8 |
| 2018 | 13 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 15 |
| 2024 | 6 |
| 2025 | 21 |
| 2026 | 33 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 97 |
| Recruiting | 34 |
| Active, not recruiting | 19 |
| Unknown status | 19 |
| Not yet recruiting | 7 |
| Withdrawn | 4 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 17 |
| Novo Nordisk A/S | 17 |
| John Sievenpiper | 12 |
| University of Toronto | 12 |
| Laval University | 10 |
| Amgen | 7 |
| AstraZeneca | 7 |
| University of British Columbia | 6 |
| University of Alberta | 5 |
| University of Guelph | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 182 |
| Obesity | 157 |
| Diabetes Mellitus, Type 2 | 31 |
| Diabetes Mellitus | 25 |
| Insulin Resistance | 22 |
| Metabolic Syndrome | 22 |
| Body Weight | 21 |
| Prediabetic State | 18 |
| Weight Loss | 17 |
| Cardiovascular Diseases | 15 |
Trials
Showing 26 to 50 of 182. Each trial links to its page on Pharma Observatory.
82 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.